Biomark Diagnostics Inc. (FRA:20B)
Germany · Delayed Price · Currency is EUR 0.3180
0.00 (0.00%)
Last updated: Jul 28, 2026, 8:02 AM CET
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €33.86 million as of July 27, 2026. Its market cap has increased by 71.39% in one year.
Market Cap
33.86M
Enterprise Value
33.50M
Revenue
57.01K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.32
ChartMarket Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 28.50M to 33.86M, an increase of 18.83%. That is a compound annual growth rate of 1.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 33.86M | 3.94% |
| Dec 30, 2025 | 32.58M | 228.85% |
| Dec 30, 2024 | 9.91M | -19.08% |
| Dec 29, 2023 | 12.24M | 23.53% |
| Dec 30, 2022 | 9.91M | -23.89% |
| Dec 30, 2021 | 13.02M | 134.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 80.40M |
| 2invest AG | 44.52M |
| Vidac Pharma Holding | 24.63M |
| co.don AG | 427.57K |
| Paion AG | 392.35K |
| bioXXmed AG | 225.65K |
| MagForce AG | 137.58K |